Clinical trial
Xarelto® on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation
NCT01606995 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Xarelto® on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 12, 2012
- Completion date
- March 31, 2015
- Enrollment
- 6,784 (actual)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.